Where Pharmacometrics Fits in Drug Development

Understand how pharmacometrics supports decisions across drug development.
Tip

What you’ll build today: a clear understanding of how PMx informs real-world drug development decisions.

Learning Objectives

  • Describe PMx roles across development
  • Explain decision impact

Key Ideas

Pharmacometrics supports:

  • dose selection
  • trial design
  • interpretation of results

Its value comes from influencing decisions—not just generating numbers.

Development Context

  • Early stage: first-in-human dose selection
  • Mid stage: exposure-response understanding
  • Late stage: confirm dosing strategy

The same model may be used across stages—but its interpretation changes.

Worked Example: Same Model, Different Decisions

You build a PK model.

In Phase 1:

  • Goal: safety
  • Decision: can we escalate dose?

In Phase 3:

  • Goal: efficacy and labeling
  • Decision: what dose should be recommended?

Same model → different decisions.

Insight

A model has no inherent meaning—its value depends on context and purpose.

Strategies

  • Always consider development stage
  • Focus on decision impact
  • Use models to explore scenarios

Common Mistakes

  • Ignoring the development stage when interpreting results
  • Misinterpreting exposure–response relationships as definitive
  • Overgeneralizing findings from one stage to another
  • Treating PMx results as purely academic rather than decision-driven
  • Ignoring clinical context when making quantitative interpretations

Practice Problems

  1. Where is PMx used?

Across all development stages

Summary

PMx is valuable because it informs decisions across development.

  • Always connect analysis to stage.
  • Focus on decision impact.
  • Context changes interpretation.